Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Cetilistat (Standard)
Cat. No.:
OB0425LY-143
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Cetilistat (Standard) is an oral lipase inhibitor that effectively reduces fat absorption.
Synonyms:
Cetilistat; 282526-98-1; 2-(Hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one; 4H-3,1-Benzoxazin-4-one, 2-(hexadecyloxy)-6-methyl-; 2-(Hexadecyloxy)-6-methyl-4H-benzo[d][1,3]oxazin-4-one
CAS No.:
282526-98-1
Compound CID:
9952916
Formula:
C25H39NO3
Formula Weight:
401.58
Specification
Target:
Others
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
Cetilistat (Standard) is primarily used in obesity research to help control weight and improve metabolic health by reducing energy intake.
